ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter

Takeda starts trials of 3 COVID drugs in US with Amgen and AbbVie

Alliance looks to test existing treatments' potential against coronavirus

An alliance of 20 partners including Takeda Pharmaceutical will test multiple drug candidates in the coming months.   © Reuters

TOKYO -- Takeda Pharmaceutical has begun clinical trials on three potential treatments for COVID-19 as part of a research and development team that includes U.S. peers Amgen and AbbVie Japan's biggest drugmaker said Tuesday.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more